Mark C. McKenna - Insider Trading & Ownership

Location
400 Somerset Corporate Boulevard, Bridgewater, NJ
Summary
The estimated net worth of Mark C. McKenna is at least $1.5M dollars as of August 11, 2025. Mark C. McKenna is the Director of Apogee Therapeutics, Inc. and owns shares of Apogee Therapeutics, Inc. (APGE) stock worth about $997K. Mark C. McKenna is the Former Director of BridgeBio Oncology Therapeutics, Inc. and owns shares of Helix Acquisition Corp. II (HLXB) stock worth about $322K. Mark C. McKenna is the Director of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $178K.
Signature
/s/ Mark C. McKenna
All Insider Reports
All Insider Reports

Ownership of Mark C. McKenna

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APGE Apogee Therapeutics, Inc. Director $997K +$991K +15916% Jun 17, 2025
HLXB Helix Acquisition Corp. II Former Director $322K Aug 11, 2025
NAMS, NAMSW NewAmsterdam Pharma Co N.V. Director $178K Jan 6, 2025
PCSC Perceptive Capital Solutions Corp Director Jun 11, 2024
RXDX Prometheus Biosciences, Inc. Chairman, President and CEO, Director Jun 16, 2023
SYRE Spyre Therapeutics, Inc. Director May 29, 2025

Insider Transactions Reported by Mark C. McKenna:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.